Researchers from India presented a study examining the effects of wheat grass juice as an iron chelator in transfusion-dependent myelodysplastic syndromes (MDS) patients on May 29 at the 2009 American Society of Clinical Oncology (ASCO) meeting.

Patients with MDS or other transfusion-dependent diseases are at risk for toxic iron build-up in cells, and possible organ damage. Iron chelators bind to excess iron for removal from the body.

The study included 20 transfusion-dependent MDS patients between the ages of 42 of 72 years (median 55 years). The participants…

The American Society of Clinical Oncology (ASCO) will be holding its 45th annual meeting in Orlando from May 29 to June 2. Myelodysplastic syndromes is just one of many oncological diseases covered at this year’s meeting.

More than 30,000 attendees are expected this year, and over 4,000 presentations and posters have been submitted from around the world. A wide variety of scientific and educational sessions are planned, with emphasis on promotion of cutting edge cancer treatment, prevention, and control.

This year’s ASCO meeting has a number of…